$1.08
-0.01 (-0.92%)
Open$1.08
Previous Close$1.09
Day High$1.08
Day Low$1.04
52W High$605.00
52W Low$225.30
Volume—
Avg Volume44.3K
Market Cap163.59M
P/E Ratio—
EPS$-1.26
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+3,599.1% upside
Current
$1.08
$1.08
Target
$39.95
$39.95
$34.56
$39.95 avg
$63.39
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 930.55M | 904.94M | 56.95M |
| Net Income | -118,751,434 | -103,934,932 | 10.61M |
| Profit Margin | -28.4% | -27.0% | 18.6% |
| EBITDA | -63,405,581 | -58,577,557 | 17.54M |
| Free Cash Flow | — | — | 14.62M |
| Rev Growth | +2.8% | +2.8% | -4.9% |
| Debt/Equity | 0.46 | 0.46 | 0.25 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |